• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

参与者报告的帕金森病基因检测的个人效用以及参与临床试验的意愿。

Participant-reported personal utility of genetic testing for Parkinson's disease and interest in clinical trial participation.

作者信息

Oas Hannah, Cook Lola, Schwantes-An Tae-Hwi, Walsh Laurence E, Wills Anne-Marie, Mata Ignacio F, Nance Martha A, Beck James C, Naito Anna, Marder Karen, Alcalay Roy N, Verbrugge Jennifer

机构信息

Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN, USA.

Department of Neurology and Pediatrics, Indiana University School of Medicine, Indianapolis, IN, USA.

出版信息

NPJ Parkinsons Dis. 2024 Oct 25;10(1):202. doi: 10.1038/s41531-024-00805-z.

DOI:10.1038/s41531-024-00805-z
PMID:39455611
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11511990/
Abstract

Genetic testing for Parkinson's disease (PD) is infrequently performed due to perceptions of low utility. We investigated the personal utility in PD GENEration and how results lead to enrollment in additional research studies. Participants (n = 972) underwent genetic testing, results disclosure, genetic counseling, and completed a survey examining the perceived personal utility of their results and interest in participating in additional studies. Most participants found their genetic test results useful, including satisfying curiosity (81%), feeling good about helping the medical community (80%), and having information to share with family (77%). There were no significant differences in responses based on result type. Forty-five percent of participants expressed interest in participating in research studies; whereas 16% of participants confirmed enrollment. Our results suggest that participants find personal utility in genetic testing regardless of results. Although participants may be interested in enrolling in additional research, they may need support and resources.

摘要

由于认为实用性较低,帕金森病(PD)的基因检测很少进行。我们调查了帕金森病基因检测项目中的个人效用,以及检测结果如何促使参与者加入其他研究。参与者(n = 972)接受了基因检测、结果告知、遗传咨询,并完成了一项调查,该调查考察了他们对检测结果个人效用的认知以及参与其他研究的兴趣。大多数参与者认为他们的基因检测结果有用,包括满足好奇心(81%)、因有助于医学界而感觉良好(80%)以及有信息可与家人分享(77%)。根据结果类型,回答没有显著差异。45%的参与者表示有兴趣参与研究;而16%的参与者确认已登记参加。我们的结果表明,无论检测结果如何,参与者都能从基因检测中找到个人效用。尽管参与者可能有兴趣参加其他研究,但他们可能需要支持和资源。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc7a/11511990/5b0d30493c0f/41531_2024_805_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc7a/11511990/5b0d30493c0f/41531_2024_805_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc7a/11511990/5b0d30493c0f/41531_2024_805_Fig1_HTML.jpg

相似文献

1
Participant-reported personal utility of genetic testing for Parkinson's disease and interest in clinical trial participation.参与者报告的帕金森病基因检测的个人效用以及参与临床试验的意愿。
NPJ Parkinsons Dis. 2024 Oct 25;10(1):202. doi: 10.1038/s41531-024-00805-z.
2
Factors Influencing Patient Disclosure of Parkinson's Disease Genetic Testing Results to Relatives.影响帕金森病遗传检测结果向亲属披露的因素。
Mov Disord Clin Pract. 2024 Jul;11(7):786-794. doi: 10.1002/mdc3.14043. Epub 2024 Apr 8.
3
Outcomes of genetic test disclosure and genetic counseling in a large Parkinson's disease research study.一项大型帕金森病研究中遗传检测结果披露和遗传咨询的结果。
J Genet Couns. 2021 Jun;30(3):755-765. doi: 10.1002/jgc4.1366. Epub 2020 Dec 15.
4
Parkinson's disease variant detection and disclosure: PD GENEration, a North American study.帕金森病变异检测与披露:北美研究项目“PD基因计划”
Brain. 2024 Aug 1;147(8):2668-2679. doi: 10.1093/brain/awae142.
5
Readiness for Parkinson's disease genetic testing and counseling in patients and their relatives in urban settings in the Dominican Republic.多米尼加共和国城市地区帕金森病患者及其亲属进行基因检测和咨询的准备情况。
NPJ Parkinsons Dis. 2023 Aug 29;9(1):126. doi: 10.1038/s41531-023-00569-y.
6
Communicative participation outcomes in individuals with Parkinson's disease receiving standard care speech-language therapy services in community settings.社区环境中接受标准护理言语治疗服务的帕金森病患者的交流参与结果。
Int J Lang Commun Disord. 2024 Mar-Apr;59(2):808-827. doi: 10.1111/1460-6984.12965. Epub 2023 Oct 19.
7
Demographic Characteristics Associated With Perceptions of Personal Utility in Genetic and Genomic Testing: A Systematic Review.与遗传和基因组检测中个人效用感知相关的人口统计学特征:系统评价。
JAMA Netw Open. 2023 May 1;6(5):e2310367. doi: 10.1001/jamanetworkopen.2023.10367.
8
Providing genetic testing and genetic counseling for Parkinson's disease to the community.为社区提供帕金森病的基因检测和遗传咨询服务。
Genet Med. 2023 Oct;25(10):100907. doi: 10.1016/j.gim.2023.100907. Epub 2023 Jun 8.
9
Parkinson's Disease: Patients' Knowledge, Attitudes, and Interest in Genetic Counseling.帕金森病:患者对遗传咨询的认知、态度及兴趣
J Genet Couns. 2018 Sep;27(5):1200-1209. doi: 10.1007/s10897-018-0239-3. Epub 2018 Mar 2.
10
Personal genomic screening: How best to facilitate preparedness of future clients.个人基因组筛查:如何更好地促进未来客户的准备工作。
Eur J Med Genet. 2019 May;62(5):397-404. doi: 10.1016/j.ejmg.2019.05.006. Epub 2019 May 11.

引用本文的文献

1
Genetic variants associated with idiopathic Parkinson's disease in Latin America: A systematic review.拉丁美洲与特发性帕金森病相关的基因变异:一项系统综述。
Neurogenetics. 2025 Apr 3;26(1):43. doi: 10.1007/s10048-025-00817-8.

本文引用的文献

1
Barriers to Clinical Trial Implementation Among Community Care Centers.社区护理中心实施临床试验的障碍。
JAMA Netw Open. 2024 Apr 1;7(4):e248739. doi: 10.1001/jamanetworkopen.2024.8739.
2
Readiness for Parkinson's disease genetic testing and counseling in patients and their relatives in urban settings in the Dominican Republic.多米尼加共和国城市地区帕金森病患者及其亲属进行基因检测和咨询的准备情况。
NPJ Parkinsons Dis. 2023 Aug 29;9(1):126. doi: 10.1038/s41531-023-00569-y.
3
Genetic Testing in Parkinson's Disease.帕金森病的基因检测。
Mov Disord. 2023 Aug;38(8):1384-1396. doi: 10.1002/mds.29500. Epub 2023 Jun 27.
4
Providing genetic testing and genetic counseling for Parkinson's disease to the community.为社区提供帕金森病的基因检测和遗传咨询服务。
Genet Med. 2023 Oct;25(10):100907. doi: 10.1016/j.gim.2023.100907. Epub 2023 Jun 8.
5
The Genetic Testing Experience of Individuals with Parkinson's Disease.帕金森病患者的基因检测经历
Mov Disord Clin Pract. 2023 Jan 2;10(2):248-257. doi: 10.1002/mdc3.13641. eCollection 2023 Feb.
6
Monogenic Parkinson's Disease: Genotype, Phenotype, Pathophysiology, and Genetic Testing.单基因帕金森病:基因型、表型、病理生理学及基因检测
Genes (Basel). 2022 Mar 7;13(3):471. doi: 10.3390/genes13030471.
7
Genetic Testing for Parkinson Disease: Are We Ready?帕金森病的基因检测:我们准备好了吗?
Neurol Clin Pract. 2021 Feb;11(1):69-77. doi: 10.1212/CPJ.0000000000000831.
8
Parkinson's disease.帕金森病。
Lancet. 2021 Jun 12;397(10291):2284-2303. doi: 10.1016/S0140-6736(21)00218-X. Epub 2021 Apr 10.
9
Outcomes of genetic test disclosure and genetic counseling in a large Parkinson's disease research study.一项大型帕金森病研究中遗传检测结果披露和遗传咨询的结果。
J Genet Couns. 2021 Jun;30(3):755-765. doi: 10.1002/jgc4.1366. Epub 2020 Dec 15.
10
Overcoming Barriers to Parkinson Disease Trial Participation: Increasing Diversity and Novel Designs for Recruitment and Retention.克服帕金森病试验参与的障碍:增加多样性和新颖的招募及保留设计。
Neurotherapeutics. 2020 Oct;17(4):1724-1735. doi: 10.1007/s13311-020-00960-0. Epub 2020 Nov 4.